Your session is about to expire
← Back to Search
Metformin for Burns (MET-ELD Trial)
MET-ELD Trial Summary
This trial will test whether metformin can help improve outcomes for elderly people who have suffered burns, by lessening the complex inflammatory and hypermetabolic responses that can occur after a burn injury.
MET-ELD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMET-ELD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 156 Patients • NCT02002221MET-ELD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I was admitted to a burn center within 5 days after getting burned.I cannot take metformin due to health reasons.I have had lactic acidosis from metformin before.I have a brain injury from lack of oxygen and am not expected to fully recover.I have type II diabetes and need insulin.I have burns covering 5% or more of my body.I will likely need surgery.I am between 60 and 99 years old.I chose not to receive treatment because of the severity of my burn injury.I have severe liver disease.My kidney function is severely reduced.I am allergic to metformin or insulin.
- Group 1: Control
- Group 2: Metformin
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being enrolled in this clinical investigation?
"Affirmative. Data posted on clinicaltrials.gov supports the notion that this medical trial, which was initially advertised on January 28th 2021 is recruiting participants at present. Around 250 people need to be recruited from a single location."
Is Metformin a novel or well-studied treatment option?
"At present, there are 170 current studies on Metformin with 43 of these trials in their third and final phase. Primarily located in Pittsburgh, Pennsylvania, 1903 distinct sites are participating in these investigations."
Are elderly individuals in their golden years eligible for this experiment?
"The trial has stringent eligibility requirements and only admits patients aged 60-99. There are 40 openings for those younger than 18 years old, while 190 slots are allocated to those over 65."
In what conditions is Metformin typically prescribed?
"Metformin has a wide range of applications, from treating exercise to managing type 1 diabetes mellitus, diabetic ketoacidosis and polycystic ovary syndrome."
Are there any openings remaining for this clinical assessment?
"As indicated by records on clinicaltrials.gov, this medical trial is currently enrolling participants. The experiment was initially made accessible to the public on January 28th 2021 and underwent its most recent revision in March 24th 2022."
What adverse effects might patients experience from Metformin use?
"Taking into account the limited evidence of its efficacy, our team deemed Metformin's safety to rate a 2."
Who is eligible to partake in this clinical experiment?
"This trial is looking to recruit 250 patients, aged 60-99 years old, with burns that cover 5% or more of their Total Body Surface Area (TBSA). Furthermore, they must have been admitted to a burn centre within 120 hours of the injury and require at least one surgical intervention."
Share this study with friends
Copy Link
Messenger